The AI Debate Fans Can’t Ignore: Digital Ozzy And The Plagiarism Row

A week of AI entertainment disputes raises questions about credit, consent and creative quality, with key allegations still unanswered.

What Big Tech’s Buyout Offers Tell Us About AI’s Price Tag

Microsoft offered eligible workers voluntary exits as Meta disclosed plans to raise up to $95 billion, reflecting the rising cost of AI investment.

Amazon Keeps AI Shopping Agents Out; Walmart Takes A Different Approach

Amazon is blocking Meta’s AI shopping agent, while Walmart is building tools for approved agents to search and buy. Key details and open questions.

Could GPT-6.1 Terra Save Money On AI Without Changing Your Workflow?

OpenAI’s GPT-6.1 Terra costs less per token than its predecessor. Independent tests show low and medium effort can reduce task costs, with lower scores.

What Businesses Should Know About IBM’s On-Prem AI Bet

IBM says open-weight AI can cut token costs for enterprises, but benchmarks, hardware use and staffing shape the economics.

How ChatGPT Is Expanding The World Of Work

OpenAI has a page titled “ChatGPT’s expanding world of work,” but available details do not identify changes, affected workers or practical impacts.

Is AI Closing In On AGI? 50 Signs Of Superintelligence Examined

A review of 50 proposed signs finds major AI progress, but definitions vary and many claims are partial, company-reported or disputed.

Did ByteDance’s Seed AI R&D Head Leave For A Startup? The Company Denies It

ByteDance disputes a report that Seed AI research head Zhou Chang left to start a company; his current role and plans remain unverified.

How AI Firm Anthropic Plans Its Big Stock Market Entry

A BBC headline reports Anthropic plans a major share listing, but no timetable, exchange, valuation or formal filing is established in the material available.

How Anthropic Says It Keeps Claude Duet From Going Rogue

A Help Net Security headline says Anthropic discussed safeguards for Claude Duet, but the available material gives no details or evidence of effectiveness.